Platford Giles Richard
President, IBU
Platford Giles Richard has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Platford Giles Richard is listed as President, IBU at TAKEDA PHARMACEUTICAL CO LTD. Inside the rolling window, Platford Giles Richard reported no open-market purchases and 1 open-market sale totaling $532K in TAK.
Companies traded
Other insiders at TAK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$532K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Platford Giles Richard made?
Platford Giles Richard has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Platford Giles Richard trade?
Platford Giles Richard has filed SEC Form 4 disclosures for 1 company, including TAK.
When was Platford Giles Richard's most recent SEC Form 4 filing?
Platford Giles Richard's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Platford Giles Richard's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Platford Giles Richard is listed as President, IBU.
What is Platford Giles Richard's total buy and sell value in the current window?
Inside the rolling retention window, Platford Giles Richard bought $0 and sold $532K based on SEC Form 4 filings.
What was Platford Giles Richard's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 31,083 TAK shares on 2026-08-10, worth $532K, per SEC Form 4 filings.